Nutex Health Inc. NUTX Line of Credit Remaining Borrowing Capacity

Line of Credit Remaining Borrowing Capacity at other companies

Moelis & CompanyMC

$4.37M-1.8%

Goldman Sachs BDCGSBD

$974.27M+35.3%

OGS

ONE GASOGS

$1.5B+11.2%

Blue Owl CapitalOWL

$1.08B+9.6%

State StreetSTT

$35.59B+4.3%

InsperityNSP

$380M+35.7%

Other financials

Income statement

See full

Revenue$216.5M+2.2%

Gross profit$91.7M-22.5%

Operating income$81.3M+0.7%

Net income$46.8M+121%

EPS (diluted)$6.52+95.8%

Balance sheet

See full

Cash & equivalents$210.6M+149%

Total debt$348.9M+4.4%

Total equity$346.3M+75.7%

Total assets$957.3M+25.6%

Cash flow

See full

Operating cash flow$75.5M+48.2%

CapEx$1.2M+1,777%

Free cash flow$74.3M+46.0%

Valuation

See full

Market cap$1.02B+62.2%

Enterprise value$1.15B+32.0%

P/E10.5×+2.0×

P/S1.2×+0.2×

Profitability

See full

Gross margin47.5%-1.3pp

Operating margin31.4%-2.2pp

Net margin11%-0.9pp

FCF margin30.6%+19.4pp

Returns & leverage

See full

Return on equity35.5%-21.2pp

Debt / equity1×-0.7×

Current ratio3.1×+0.9×

Where this comes from

Reported directly by Nutex Health Inc. in its filing.

Tagged under the XBRL concept us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity.

The official record: Nutex Health Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nutex Health Inc.'s line of credit remaining borrowing capacity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Nutex Health Inc.'s line of credit remaining borrowing capacity?: Nutex Health Inc. (NUTX) reported line of credit remaining borrowing capacity of $3.4M in Q1 2026.